Effect of Vitamin B6 on Breast pain in women

Evaluation of effect of Vitamin B6 on Mastalgia in women in Amiralmomenin Hospital, Semnan

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014011715162N3

Enrollment

100

Registered

2014-02-14

Start date

2012-05-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastalgia. Mastodynia

Interventions

Intervention 1: Control group: placebo (sugar in the capsules similar to case group), BD for two months. Intervention 2: Case group: Vitamin B6 (manufactured by Ramopharmin Pharmaceutical Lab. Tehran

Placebo

Treatment - Drugs

Control group: placebo (sugar in the capsules similar to case group), BD for two months

Case group: Vitamin B6 (manufactured by Ramopharmin Pharmaceutical Lab. Tehran – Iran), 100 mg BD for two months

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Mastalgia; Their pain doesn’t relieve in spite of reassurance and they return back Exclusion criteria: Breast mass; History of breast trauma; History of breast cancer or breast surgery; Patients suspicious to breast cancer; Existence of extramamary source for preast pain (chest pain, osteochnderitis, ...); Pregnancy; Lactation; Hormonal drugs or OCP consumption

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mastalgia. Timepoint: End of first month, end of second month. Method of measurement: Visual analogue scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Jafar Alavy Toussy

Semnan University of Medical Sciences

drtoussy@yahoo.comdrtoussy@sem-ums.ac.ir+98 23 1443 7822

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026